title: Sustained Complete Molecular Remission After Discontinuation of Tyrosine Kinase Inhibitors in Blast-Phase Chronic Myeloid Leukemia.
authors.affiliation: The Winship Cancer Institute of Emory University, Atlanta, GA.
authors.forename: Brittany G
authors.initials: BG
authors.lastname: Hill
authors.affiliation: The Winship Cancer Institute of Emory University, Atlanta, GA.
authors.forename: Ann Qi
authors.initials: AQ
authors.lastname: Shen
authors.affiliation: The Winship Cancer Institute of Emory University, Atlanta, GA.
authors.forename: Fuad
authors.initials: F
authors.lastname: El Rassi
authors.affiliation: The Winship Cancer Institute of Emory University, Atlanta, GA hkhoury@emory.edu.
authors.forename: Hanna Jean
authors.initials: HJ
authors.lastname: Khoury
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001752:Blast Crisis / Q000473:pathology*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D012074:Remission Induction
chemical_list: D047428:Protein Kinase Inhibitors